Industry & Mining · Pharmaceutical active pharmaceutical ingredients (APIs) production

Pharmaceutical active pharmaceutical ingredients (APIs) production in France in 2026

France does not engage in industrial production of active pharmaceutical ingredients (APIs) — the figure stands at 0 tonnes in 2026. Despite being home to giants like Sanofi, French pharmaceutical companies have historically focused on drug development and final formulation rather than the synthesis of raw substances. API production has largely moved to China and India, where production costs and environmental regulations are lower. France, meanwhile, maintains its leadership in research and clinical trials. In the global ranking of 197 countries, the country holds 33-th place.

Data for 2026 · unit: tonnes
Position

France world ranking

#33 / 197

Country position on the scale from last to first place for this indicator.

FR
#33
#197#1
Trend

Change over time

Change in indicator over the available period.

30
1950
150
1990
200
2000
0
2010
0
2020
0
2025
0
2026

Values — tonnes

Comparison

Top countries by Pharmaceutical active pharmaceutical ingredients (APIs) production

Where France stands in the world ranking.

Full world rankingarrow_forward
Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical active pharmaceutical ingredients (APIs) production in France — how much?
Based on 2026 data — 0 tonnes. This is rank #33 out of 197 countries.
What is France's rank by Pharmaceutical active pharmaceutical ingredients (APIs) production?
France ranks #33 out of 197 countries in the world ranking by «Pharmaceutical active pharmaceutical ingredients (APIs) production».
How has Pharmaceutical active pharmaceutical ingredients (APIs) production changed in France?
Over the available period the indicator changed from 30 to 0 tonnes.